Skip to main content
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells
Published Web Location
http://europepmc.org/articles/PMC4414195?pdf=renderNo data is associated with this publication.
Abstract
Alterations of the EGFR/ERK and Hippo/YAP pathway have been found in nonsmall cell lung cancer (NSCLC). Herein, we show that ERK1 and ERK2 have an effect on the Hippo/YAP pathway in human NSCLC cells. Firstly, inhibition of ERK1/2 by siRNA or small-molecul
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.